Kisspeptin Levels in Early Pregnancy
Can Kisspeptin be Used for Differential Diagnosis of Early Pregnancies?
1 other identifier
observational
88
1 country
1
Brief Summary
Kisspeptins are a family of neuropeptides that are critical for the puberty initiation and female fertility. The investigators aimed to investigate in this study kisspeptin levels in early pregnancy, ectopic pregnancy, and early pregnancy loss.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 5, 2019
CompletedFirst Submitted
Initial submission to the registry
April 29, 2020
CompletedFirst Posted
Study publicly available on registry
May 1, 2020
CompletedMay 5, 2020
May 1, 2020
7 months
April 29, 2020
May 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Kisspeptin levels in early pregnancy
Kisspeptin levels can be used for discrimination between ectopic pregnancy and incomplete miscarriage.
January 2019-January 2020
Study Arms (4)
Group 1
Ectopic pregnancy
Group 2
Early viable pregnancy
Group 3
incomplete miscarriage
Group 4
Healthy women
Interventions
blood test (serum samples) for biochemical examination
Eligibility Criteria
Women were considered for the study if they presented between 5-6 weeks of gestation by last menstrual period. Patients were included if they had either confirmed intrauterine pregnancy (IUP) by ultrasound (n=22) or confirmed miscarriage (SAB) by ultrasound (n=20) or ectopic pregnancy.
You may qualify if:
- Women aged between 18-37 years presented with between 5-6 weeks of gestation by last menstrual period.
You may not qualify if:
- Women older than 37 years or younger than 18 years
- Women with a molar pregnancy, multiple gestations, gestational age past 6 weeks at the time of blood draw, or if pregnancies were assisted conceptions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Semra Yuksellead
Study Sites (1)
Gaziosmanpasa Taksim Education and Research Hospital
Istanbul, Turkey (Türkiye)
Biospecimen
Kisspeptin is a family of peptide hormones encoded by the KISS1 gene. Kisspeptin acts centrally via the kisspeptin receptor to stimulate the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus and has a critical role in the initiation of puberty. Kisspeptin was first discovered as an inhibitor of tumor metastasis and, as a result, was previously known as metastatin. Kisspeptin is also found in high levels in first-trimester syncytiotrophoblast cells.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
sibel bektas, proffessor
Gaziosmanpasa Taksim Education and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 6 Months
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal investigator, MD
Study Record Dates
First Submitted
April 29, 2020
First Posted
May 1, 2020
Study Start
January 5, 2019
Primary Completion
August 1, 2019
Study Completion
November 5, 2019
Last Updated
May 5, 2020
Record last verified: 2020-05